Search Results for: SRC

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
MICAL1 microtubule associated monooxygenase, calponin and LIM domain containing 1
  • Factors involved in megakaryocyte development and platelet production
MPZL1 myelin protein zero like 1
NANS N-acetylneuraminate synthase
  • Sialic acid metabolism
NCOA6 nuclear receptor coactivator 6
  • RORA activates gene expression
  • BMAL1:CLOCK,NPAS2 activates circadian gene expression
  • PPARA activates gene expression
  • PPARA activates gene expression
  • Transcriptional activation of mitochondrial biogenesis
  • Activation of gene expression by SREBF (SREBP)
  • Transcriptional regulation of white adipocyte differentiation
  • Regulation of lipid metabolism by PPARalpha
  • Circadian Clock
  • Activation of anterior HOX genes in hindbrain development during early embryogenesis
NEDD4 NEDD4 E3 ubiquitin protein ligase
  • ISG15 antiviral mechanism
  • Downregulation of ERBB4 signaling
  • Regulation of PTEN localization
  • Regulation of PTEN stability and activity
  • Antigen processing: Ubiquitination & Proteasome degradation
NPHS1 NPHS1 adhesion molecule, nephrin
  • Nephrin family interactions
  • Nephrin family interactions
  • Nephrotic syndrome and focal segmental glomerulosclerosis
PDCD6IP programmed cell death 6 interacting protein
  • Budding and maturation of HIV virion
  • Uptake and function of anthrax toxins
  • RIPK1-mediated regulated necrosis
  • Regulation of necroptotic cell death
PECAM1 platelet and endothelial cell adhesion molecule 1
  • Platelet degranulation
  • Cell surface interactions at the vascular wall
  • PECAM1 interactions
  • Integrin cell surface interactions
  • Platelet sensitization by LDL
  • Neutrophil degranulation
PELP1 proline, glutamate and leucine rich protein 1
  • Major pathway of rRNA processing in the nucleolus and cytosol
  • PTK6 Expression
PIP5K1C phosphatidylinositol-4-phosphate 5-kinase type 1 gamma
  • Synthesis of PIPs at the plasma membrane
  • SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion
  • PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
  • Clathrin-mediated endocytosis
  • Lethal congenital contractural syndrome (LCCS)
PKD1 polycystin 1, transient receptor potential channel interacting
  • VxPx cargo-targeting to cilium
  • VxPx cargo-targeting to cilium
  • Polycystic kidney disease
PLCG1 phospholipase C gamma 1
  • ISG15 antiviral mechanism
  • Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
  • PLCG1 events in ERBB2 signaling
  • DAG and IP3 signaling
  • PLC-gamma1 signalling
  • Synthesis of IP3 and IP4 in the cytosol
  • Downstream signal transduction
  • Generation of second messenger molecules
  • Role of phospholipids in phagocytosis
  • Role of phospholipids in phagocytosis
  • PECAM1 interactions
  • EGFR interacts with phospholipase C-gamma
  • DAP12 signaling
  • FCERI mediated MAPK activation
  • FCERI mediated Ca+2 mobilization
  • FCERI mediated Ca+2 mobilization
  • Role of second messengers in netrin-1 signaling
  • VEGFR2 mediated cell proliferation
  • VEGFR2 mediated cell proliferation
  • Constitutive Signaling by EGFRvIII
  • Phospholipase C-mediated cascade: FGFR1
  • Phospholipase C-mediated cascade; FGFR2
  • Phospholipase C-mediated cascade; FGFR3
  • Phospholipase C-mediated cascade; FGFR4
  • Signaling by FGFR2 in disease
  • Signaling by FGFR4 in disease
  • Signaling by FGFR1 in disease
  • Signaling by FGFR3 point mutants in cancer
  • RET signaling
  • Activated NTRK2 signals through PLCG1
  • Activated NTRK2 signals through PLCG1
  • Erythropoietin activates Phospholipase C gamma (PLCG)
  • Activated NTRK3 signals through PLCG1
  • Activated NTRK3 signals through PLCG1
  • FCGR3A-mediated IL10 synthesis
  • Signaling by ERBB2 KD Mutants
  • Signaling by ERBB2 ECD mutants
  • Signaling by ERBB2 TMD/JMD mutants
PLSCR1 phospholipid scramblase 1
PRKCH protein kinase C eta
  • Effects of PIP2 hydrolysis
  • G alpha (z) signalling events
PROM1 prominin 1
  • Macular degeneration, including: Age-related macular degeneration (ARMD); Patterned dystrophy of retinal pigment epithelium (PDREP); Retinal macular dystrophy 2 (MCDR2); X-linked atrophic macular degeneration (MDXLA)
  • Cone-rod dystrophy and cone dystrophy, including: Cone-rod dystrophy (CORD); Cone dystrophy (COD); Retinal cone dystrophy (RCD)
  • Stargardt disease (STGD); Fundus flavimaculatus
  • Retinitis pigmentosa (RP)
PTPA protein phosphatase 2 phosphatase activator
PTPN18 protein tyrosine phosphatase non-receptor type 18
  • Downregulation of ERBB2 signaling
  • Interleukin-37 signaling
PTPN2 protein tyrosine phosphatase non-receptor type 2
  • Negative regulation of MET activity
  • Interleukin-37 signaling
  • Type I diabetes mellitus
PTPN21 protein tyrosine phosphatase non-receptor type 21
PTPRA protein tyrosine phosphatase receptor type A
  • NCAM signaling for neurite out-growth
  • NCAM signaling for neurite out-growth
  • RAF/MAP kinase cascade

Page 13 out of 16 pages